We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Symbios Risk Analysis, CAPAs Bring Form 483
Symbios Risk Analysis, CAPAs Bring Form 483
September 5, 2013
Symbios Medical Products failed to revalidate its manufacturing process for modified flow restrictor subassemblies (FRSAs) used in infusion pumps after it corrected an issue, a Form 483 says.